PIONEERING NEW POSSIBILITIES IN BIOELECTRONIC MEDICINE
SetPoint Medical is pioneering bioelectronic medicine to offer patients and providers a potentially safe and cost-effective approach for treatment of chronic autoimmune diseases.
The convergence of extraordinary advances in immunology, neuroscience and bioengineering have resulted in an entirely new treatment approach.Learn more about the science
SetPoint Medical’s platform uses a
small, implantable device to deliver
targeted electrical pulses along existing
physiologic pathways to trigger the
body’s own biological responses.
SetPoint Medical has brought together a unique group of professionals with expertise across medical devices, pharmaceuticals and consumer technology fields to assemble a team dedicated to improving patient care.
April 30, 2019
SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for T...Read Press Release from
October 23, 2018
SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of ...Read Press Release from
October 16, 2018
We're excited to have our President and CEO Murthy Simhambhatla, PhD present at the Bank of America Merrill...Read on LinkedIn
Pain Medicine News recently covered our positive long-term 24-month results, which support the ongoing clin...Read on LinkedIn
INVESTIGATIONAL DEVICE DISCLAIMER: The SetPoint Medical device is an investigational device. It is currently undergoing clinical evaluation under Food and Drug Administration’s Investigational Device Exemption and is not approved for commercial use.